Chronic Lymphocytic Leukemia

Showing NaN - NaN of 41

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Fountain Valley, California
  • +201 more
Jan 16, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Bendamustine, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Los Angeles, California
  • +142 more
Jan 10, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
  • +11 more
Nov 23, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

Completed
  • Chronic Lymphocytic Leukemia
  • Louisville, Kentucky
  • +66 more
Nov 9, 2022

Chronic Lymphocytic Leukemia, Hypogammaglobulinemia Trial in Worldwide (Panzyga, Placebo)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Hypogammaglobulinemia
  • Panzyga
  • Placebo
  • Saint Petersburg, Florida
  • +52 more
Aug 10, 2022

Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))

Recruiting
  • Multiple Myeloma
  • +13 more
  • RITA (App)
  • Milano, Italy
    ASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
Jul 6, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Phoenix, Arizona
  • +116 more
Jun 27, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib (ACP-196)
  • +3 more
  • Chandler, Arizona
  • +156 more
Jun 2, 2022

Chronic Lymphocytic Leukemia Treated With Idelalisib and

Completed
  • Chronic Lymphocytic Leukemia
  • idelalisib and rituximab
  • Cona, Ferrara, Italy
  • +37 more
May 11, 2022

Hepatitis B Reactivations in Patients Affected by Chronic

Completed
  • Chronic Lymphocytic Leukemia
  • Cona, Ferrara, Italy
  • +22 more
May 11, 2022

Chronic Lymphocytic Leukemia Trial in Milano (Venetoclax, Imbruvica Oral Product)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Milano, MI, Italy
    Ospedale San Raffaele
Apr 2, 2022

Chronic Lymphocytic Leukemia Trial in Milano (Ibrutinib and obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Ibrutinib and obinutuzumab
  • Milano, MI, Italy
    Strategic Research Program on CLL
Apr 2, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +165 more
Mar 24, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Chandler, Arizona
  • +107 more
Mar 8, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Study on the Diagnosis and Management of CLL in Italy by GIMEMA

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
    • Alessandria, Italy
    • +17 more
    Jan 3, 2022

    Relapsed or Refractory Chronic Lymphocytic Leukemia

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Cona, Ferrara, Italy
    • +26 more
    Jan 3, 2022

    CLL, Chronic Lymphocytic Leukemia Trial in Milano, Torino (Peripheral blood samples withdrawal)

    Recruiting
    • CLL
    • Chronic Lymphocytic Leukemia
    • Peripheral blood samples withdrawal
    • Milano, Italy
    • +1 more
    Jan 3, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

    Completed
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +2 more
    • Tafasitamab
    • +2 more
    • Jacksonville, Florida
    • +16 more
    Dec 10, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Little Rock, Arkansas
    • +144 more
    Dec 3, 2021

    Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient

    Completed
    • Chronic Lymphocytic Leukemia
    • Ascoli Piceno, Italy
    • +46 more
    Sep 6, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Post-Chlorambucil Therapy Follow-up
    • +4 more
    • Duarte, California
    • +106 more
    Aug 6, 2021